D-Wave Quantum closed Friday down 6.7%, caught in a broad technology selloff rather than tripped by any company-specific bad news. Reports attributed the pressure to Intel’s results and Amazon’s spending plans, which sharpened worries about the cost and payoff of heavy investment in artificial intelligence infrastructure. Other quantum computing names fell alongside it.
That distinction matters, but it cuts both ways. A sector-wide move is no evidence of operational deterioration at D-Wave — and no reassurance either. It simply doesn’t address whether the company can turn its technology into money.
Two Announcements, One Test
The company’s own news this week concerns research applications and a planned partnership. On Wednesday, D-Wave reported that customer Shionogi took first place in the quality-of-life category of the NEDO Quantum Computing Challenge, with research examining how quantum computers can be used in drug discovery. According to D-Wave, the awarded work included a peer-reviewed study drawing on the company’s quantum annealing technology, and a ¥40 million prize supports continuation of the project.
That is a concrete application proof point from research. It is not a customer order for D-Wave, and no revenue contribution has been quantified.
The same caution applies to the non-binding memorandum of understanding with LG CNS, also announced Wednesday. The two companies intend to explore optimization applications for enterprise customers in South Korea and international markets, covering joint customer development and marketing activities in manufacturing, telecommunications, financial services and retail. No committed contract volume was disclosed. For investors, the significance lies in possible business opportunities, not secured revenue.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
What the Share Price Doesn’t Answer
It would be too convenient to wave off the decline as meaningless. A company can report progress and still come under pressure on the exchange; the useful question is what economic weight those advances carry. Shionogi’s prize strengthens the application case but answers a different question than the one about D-Wave’s commercial development. Likewise, the LG CNS agreement is a starting point for possible progress, not a substitute for proving it.
Neither a blanket crisis verdict from the share-price drop nor quick optimism from the project announcements holds up. D-Wave is providing evidence of practical uses for its technology. How those uses translate into business results is what remains unresolved.
November 10 Becomes the Next Fixed Marker
D-Wave has scheduled third-quarter 2026 results for November 10, before the market opens. That date offers the next opportunity to weigh the research and partnership news against actual business performance — and to move the discussion back toward the numbers.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from November 1 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 1.
D-Wave Quantum: Buy or sell? Read more here...
